5,194
Total Claims
$682K
Drug Cost
308
Beneficiaries
$2,214
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-42%
Opioid rate vs peers
1.3% vs 2.2% avg
+57%
Cost per patient vs peers
$2,214 vs $1,411 avg
+73%
Brand preference vs peers
18.4% vs 10.6% avg
Opioid Prescribing
1.3%
Opioid Rate
67
Opioid Claims
$949
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
82% generic
Brand: 938 claims · $570K
Generic: 4,160 claims · $107K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 161 | $127K |
| Dulaglutide | 104 | $108K |
| Semaglutide | 40 | $47K |
| Semaglutide | 30 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 38 | $31K |
| Linagliptin | 24 | $20K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 41 | $14K |
| Tiotropium Bromide | 28 | $14K |
| Sitagliptin Phosphate | 16 | $14K |
| Apixaban | 15 | $11K |
| Ipratropium Bromide | 20 | $11K |
| Atorvastatin Calcium | 427 | $9,606 |
| Umeclidinium Brm/Vilanterol Tr | 16 | $7,086 |
| Ipratropium/Albuterol Sulfate | 15 | $6,996 |
Prescribing Profile
Patient Profile
70
Avg Age
62%
Female
1.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data